ARCHIVES

Nader Group Backs FDA In controversy Over Drug Testing

This article is from The Cancer Letter archive.

Vol. 03 No. 06 | February 11, 1977

Download PDF Visit The Full Archive

Related Articles

Cancer Screening Priorities Questioned In Dartmouth Study

March 28, 2003

Drug Discover Groups Recompetition Approved, But Advisors Scale Back Model Development

March 15, 1991

NCAB Approves Addition Of Two New Organ Systems

February 14, 1986

Men With PSA Of 7 Or Higher More Likely To Have Biopsy

February 25, 2005

FCRF Program Proving Good Basic Research Can Be Supported By NCI With a Contract

January 23, 1987

OSCC Groups Send Four Concepts To NCI Board

September 13, 1985